Emergency approval of the antiviral drug remdesivir is the first good news of this pandemic. This is how Gilead Sciences prepared for the moment.

Hosts: Carol Massar and Jason Kelly. Producer: Doni Holloway.

Learn more about your ad-choices at https://www.iheartpodcastnetwork.com